CBDv Isolate

CBDV is very similar to CBD, as it is only a slight molecular change to its structure. The cannabinoid is derived from hemp and has similar properties to CBD. In a 2019 study conducted by Translational Psychiatry, they used a double-blind test wanted to compare how CBD and CBDV affected the brain and how it impacts individuals with Autism Spectrum Disorder (ASD). 

CBD studies found, according to this study, that the effects of CBD on brain excitatory (E) glutamate and inhibitory (I) γ-aminobutyric acid (GABA) – given that E-I abnormalities may be one of the key mechanisms underpinning ASD³. We found that CBD modulated glutamate-GABA systems in both ASD and neurotypicals, but that prefrontal GABA systems responded differently in ASD. Specifically, CBD decreased prefrontal GABA levels in ASD but not in controls. These findings contributed to increasing evidence that an important effect of therapeutic compounds derived from Cannabis sativa may be the ‘shifting’ of brain E-I systems.

This does not mean that it directly cures or treats ASD, but has shown some promise that they want to continue to study. They noted in their conclusion that “CBDV can ‘shift’ subcortical levels of the brain’s primary excitatory metabolite glutamate (measured as Glx) both in the neurotypical and autistic brain; but that there may be significant response variability in ASD. These findings add to our understanding of the effects of CBDV Isolate Bulk in the adult human brain. Nonetheless, future studies will need to explore (i) the mechanisms of action of CBDV.” 

Why Is This Significant?

Well, it shows that this cannabinoid does have measurable impacts on the brain that can be used. In a sense, it reduces stimulation, in our opinion, so that the user can focus and think more clearly. This has not been proven but shows signs of the capabilities.